Caffeine Research Today is a free monthly online journal that collates and summarizes the latest research about Caffeine, including details on addiction, drugs, effects, coffee.

Volume 7 (2010), Issue 9 (September)

1. Randomized double-blind placebo-controlled crossover study of caffeine in patients with intermittent claudication.
   Br J Surg, 97(10): 1503-10. [Abstract] [Full-text]
2. Coffee, decaffeinated coffee, caffeine, and tea consumption in young adulthood and atherosclerosis later in life: the CARDIA study.
   Arterioscler Thromb Vasc Biol, 30(10): 2059-66. [Abstract] [Full-text]
3. Methylxanthines and human health: epidemiological and experimental evidence.
   Handb Exp Pharmacol, 200: 509-48. [Abstract] [Full-text]
4. Methylxanthines and drug dependence: a focus on interactions with substances of abuse.
   Handb Exp Pharmacol, 200: 483-507. [Abstract] [Full-text]
5. Methylxanthines, inflammation, and cancer: fundamental mechanisms.
   Handb Exp Pharmacol, 200: 469-81. [Abstract] [Full-text]
6. Methylxanthines and inflammatory cells.
   Handb Exp Pharmacol, 200: 457-68. [Abstract] [Full-text]
7. The cardiovascular effects of methylxanthines.
   Handb Exp Pharmacol, 200: 413-37. [Abstract] [Full-text]
8. Methylxanthines and the kidney.
   Handb Exp Pharmacol, 200: 391-412. [Abstract] [Full-text]
9. Methylxanthines during pregnancy and early postnatal life.
   Handb Exp Pharmacol, 200: 373-89. [Abstract] [Full-text]
10. Methylxanthines and reproduction.
    Handb Exp Pharmacol, 200: 349-72. [Abstract] [Full-text]
11. Methylxanthines and sleep.
    Handb Exp Pharmacol, 200: 331-48. [Abstract] [Full-text]
12. Methylxanthines and pain.
    Handb Exp Pharmacol, 200: 311-29. [Abstract] [Full-text]
13. Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies.
    Handb Exp Pharmacol, 200: 267-310. [Abstract] [Full-text]
14. Notes on the history of caffeine use.
    Handb Exp Pharmacol, 200: 1-9. [Abstract] [Full-text]
15. Methylxanthines and human health: epidemiological and experimental evidence.
    Handb Exp Pharmacol, 200: 509-48. [Abstract] [Full-text]
16. Methylxanthines and drug dependence: a focus on interactions with substances of abuse.
    Handb Exp Pharmacol, 200: 483-507. [Abstract] [Full-text]
17. Methylxanthines, inflammation, and cancer: fundamental mechanisms.
    Handb Exp Pharmacol, 200: 469-81. [Abstract] [Full-text]
18. Methylxanthines and inflammatory cells.
    Handb Exp Pharmacol, 200: 457-68. [Abstract] [Full-text]
19. The cardiovascular effects of methylxanthines.
    Handb Exp Pharmacol, 200: 413-37. [Abstract] [Full-text]
20. Methylxanthines and the kidney.
    Handb Exp Pharmacol, 200: 391-412. [Abstract] [Full-text]
21. Methylxanthines during pregnancy and early postnatal life.
    Handb Exp Pharmacol, 200: 373-89. [Abstract] [Full-text]
22. Methylxanthines and reproduction.
    Handb Exp Pharmacol, 200: 349-72. [Abstract] [Full-text]
23. Methylxanthines and sleep.
    Handb Exp Pharmacol, 200: 331-48. [Abstract] [Full-text]
24. Methylxanthines and pain.
    Handb Exp Pharmacol, 200: 311-29. [Abstract] [Full-text]
25. Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies.
    Handb Exp Pharmacol, 200: 267-310. [Abstract] [Full-text]
26. Notes on the history of caffeine use.
    Handb Exp Pharmacol, 200: 1-9. [Abstract] [Full-text]
27. Methylxanthines and human health: epidemiological and experimental evidence.
    Handb Exp Pharmacol, 200: 509-48. [Abstract] [Full-text]
28. Methylxanthines and drug dependence: a focus on interactions with substances of abuse.
    Handb Exp Pharmacol, 200: 483-507. [Abstract] [Full-text]
29. Methylxanthines, inflammation, and cancer: fundamental mechanisms.
    Handb Exp Pharmacol, 200: 469-81. [Abstract] [Full-text]
30. Methylxanthines and inflammatory cells.
    Handb Exp Pharmacol, 200: 457-68. [Abstract] [Full-text]
31. The cardiovascular effects of methylxanthines.
    Handb Exp Pharmacol, 200: 413-37. [Abstract] [Full-text]
32. Methylxanthines and the kidney.
    Handb Exp Pharmacol, 200: 391-412. [Abstract] [Full-text]
33. Methylxanthines during pregnancy and early postnatal life.
    Handb Exp Pharmacol, 200: 373-89. [Abstract] [Full-text]
34. Methylxanthines and reproduction.
    Handb Exp Pharmacol, 200: 349-72. [Abstract] [Full-text]
35. Methylxanthines and sleep.
    Handb Exp Pharmacol, 200: 331-48. [Abstract] [Full-text]
36. Methylxanthines and pain.
    Handb Exp Pharmacol, 200: 311-29. [Abstract] [Full-text]
37. Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies.
    Handb Exp Pharmacol, 200: 267-310. [Abstract] [Full-text]
38. Notes on the history of caffeine use.
    Handb Exp Pharmacol, 200: 1-9. [Abstract] [Full-text]
39. Application of phase-trafficking methods to natural products research.
    J Nat Prod, 73(9): 1568-72. [Abstract] [Full-text]

© 2004-2012 Caffeine Research Today. All Rights Reserved.